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A B S T R A C T
Background: Collaborative, nurse-led care is a well-established model of ambulatory care in many
healthcare systems. Nurses play a key role in managing patients’ conditions as well as in enhancing
symptom- and self-management skills.
Objective: The SMADS trial evaluated the effectiveness of a primary care-based, nurse-led, complex
intervention to promote self-management in patients with anxiety, depressive or somatic symptoms.
Change in self-efﬁcacy 12 months post baseline was used as the primary outcome.
Design: The SMADS trial set up a two-arm, cluster randomised controlled trial in the city of Hamburg, a
large metropolitan area in the North West of Germany.
Setting: We randomly allocated participating primary care practices to either the intervention group (IG),
implementing a nurse-led collaborative care model, or to the control group (CG), where patients with the
above psychosomatic symptoms received routine treatment.
Participants: Patients from 18 to 65 years of age, regularly consulting a participating primary care practice,
scoring  5 on the anxiety, depressive or somatic symptom scales of the Patient Health Questionnaire
(PHQ-D), German version.
Methods: A mixed model regression approach was used to analyse the outcome data. Analyses were based
on the intention-to-treat population: All enrolled patients were analysed at their follow-up. Additionally,
we reported results as effect sizes. The robustness of the results was investigated by performing an
observed cases analysis.
Results: 325 participants (IG N = 134, CG N = 191) from ten practices in each study arm consented to take
part and completed a baseline assessment. The mean group difference (ITT-LOCF, IG vs. CG) in self-
efﬁcacy at the post baseline follow-up (median 406 days) was 1.65 points (95% CI 0.50–2.8) in favour of IG
(p = 0.004). This amounts to a small Cohen’s d effect size of 0.33. An observed cases analysis (168
participants, IG = 56, CG = 105) resulted in a mean difference of 3.13 (95% CI 1.07–5.18, p = 0.003) between
the groups, amounting to a moderate effect size of d = 0.51.
Conclusion: A complex, nurse-led intervention, implemented as a collaborative care model, increased
perceived self-efﬁcacy in patients with symptoms of anxiety, depression or somatisation compare to
control patients. For the ﬁrst time in the German healthcare system, the SMADS trial validated the belief
that a nurse can successfully complement the work of a general practitioner – particularly in supporting
self-management of patients with psychosomatic symptoms and their psychosocial needs.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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 Complex interventions including patient education, case man-
agement by nurses and a better integration of primary and
secondary care improve patient outcomes.
 Nurse-led interventions enhance the self-care of patients with
chronic conditions including depressive disorders.
 Nurse-led care is established in several health care systems (UK,
USA, Australia, Sweden etc.) but not in Germany.
 Self-efﬁcacy is an important prerequisite for successful self-
management.
What this paper adds
 Results of the ﬁrst primary care-based, nurse-led, complex
intervention to support self-management of patients with
anxiety, depressive or somatic symptoms in Germany.
 Patients in the intervention group reported a signiﬁcant increase
in self-efﬁcacy (primary outcome) compared to the control
group (intention-to-treat analysis) at the 12-months follow-up,
the reduction of depressive and anxiety symptoms differed
signiﬁcantly among the groups.
 An account of the barriers and difﬁculties faced by scientiﬁcally
driven researchers when implementing an innovative healthcare
model into a profoundly sceptical professional environment.
1. Introduction
Anxiety, depressive and somatoform disorders (hereafter
referred to as ADSom disorders) belong to the most common
mental disorders in primary care (Toft et al., 2005). ADSom
disorders play a substantial part in the utilisation of the
healthcare system (Grabe et al., 2009). Also, ADSom disorders
cause signiﬁcant direct and indirect healthcare costs (Olesen et al.,
2012).
Practice nurses play a key role in managing patients’ conditions,
enhancing clinical and self-management skills and the care
intensity (Wagner, 2000). Nurse-led care is a well-established
concept, addressing the aforementioned problems. It features a
multi-professional approach to patient care, incorporating a
structured management plan, follow-up schedules and enhanced
inter-professional communication (Gunn et al., 2006). Evidence to
support a nurse-led collaborative care model in patients with
depressive symptoms has been veriﬁed in several systematic
reviews. Thota et al. (2012) concluded that nurse-led care improves
depressive symptoms, adherence to treatment, response to
treatment, recovery from symptoms, quality of life and care
satisfaction amongst patients. Ekers et al. (2013) reported a
considerable and consistent beneﬁt of nurse-led clinical trials over
routine treatment for depressive disorders when summarising the
results of fourteen different trials. In a review of different care
models for depressive disorders, Christensen et al. (2008)
concluded that nurse-delivered care combined with psychological
or psychiatric care was effective. Aragones et al. (2012) and
Richards et al. (2013) reported a signiﬁcant reduction in depressive
symptoms in cluster randomised collaborative care studies. Even
beyond depression, nurses can make a difference. In a secondary
analysis of trial data, Tyrer et al. (2015) compared nurse-delivered
care with the treatment offered by assistant psychologists and
graduate health workers. Improvement in anxiety and depressive
symptoms were twice as likely in the nurse care groups as in those
of the other professional groups. Oosterbaan et al. (2013)
successfully implemented a collaborative care model for a broad
range of common mental disorders. Gilbody et al. (2003) identiﬁedeffective strategies in caring for patients with depressive
disorders: clinician education, case management through nurses
and a greater degree of integration of primary and secondary care.
Types and roles of nursing professionals in primary care vary
considerably between healthcare systems (Freund et al., 2015). For
example, nurse-led interventions are part of routine, ambulatory
care in several healthcare systems (UK, USA, Australia, Netherlands
etc.) but not in Germany. Nurses in those countries usually have an
academic education and are employed as advanced practice
nurses. This kind of professional education is about to emerge
in Germany even though legal constraints prevent nurses from any
autonomously organised, professional care regularly offered in
those aforementioned healthcare systems. Thus, nurse-led inter-
ventions in ambulatory healthcare are largely unknown inGer-
many. We only know of one trial, that has tried to implement a
nurse-led intervention (Herber et al., 2009). Nevertheless,
patients with ADSom disorders can ﬁnd many services in the
German social security system: helpdesks, helplines, publicly
funded self-help groups, non-proﬁt counselling services, com-
munity-based social psychiatric support, day clinics, rehabilita-
tion services, re-integration services after long sick leaves,
specialist medical care (psychiatrist, psychotherapist). Although
these services exist, patients with ADSom disorders have
difﬁculties accessing services. Information has to be collected,
paperwork has to be ﬁlled out, appointments have to be made and
so on, all of which are impeded by their psychiatric symptoms
(Thielke et al., 2007). Eventually, there is a lack of coordination
amongst these services and the patients’ primary care practice as
it is beyond the scope of the GPs’ daily work to coordinate the
different services.
Hence, nurses can make a difference in improving healthcare.
1.1. Objective
The objective of the “Self-Management Support for Anxiety,
Depression and Somatoform Disorders in Primary Care”
(SMADS) trial was to evaluate the effectiveness of a primary
care-based, complex intervention promoting self-management
of patients presenting anxiety, depressive or somatic symptoms,
the latter denoting unspeciﬁc physical complaints, a potential
proxy for somatisation and somatoform disorder (Kroenke et al.,
2010) The SMADS trial investigated whether a nurse, collabo-
rating with a GP, addressing the psychosocial needs of ADSom
patients, could enhance the patients’ self-efﬁcacy (a proxy for
self-management) compared to receiving only routine care.
Perceived self-efﬁcacy is an important prerequisite for
successful self-management (Freund et al., 2013). The concept
is theoretically and empirically well founded (Barlow et al., 2005)
and was originally developed by Albert Bandura in the 1970s. Self-
efﬁcacy comprises one’s conﬁdence to carry out behaviour
necessary to reach a desired goal. Self-efﬁcacy is enhanced
when patients succeed in solving patient-identiﬁed problems.
Based on improved self-efﬁcacy patients can regain control of
their own lives, gaining new conﬁdence in their ability to perform
a task, hence increasing self-management (Bodenheimer et al.,
2002).
As we focused on a group of patients presenting three different
yet overlapping disorders, we chose self-efﬁcacy as a primary
outcome for the SMADS trial to obtain an overarching measure of
effectiveness. Furthermore, we investigated if a nurse-led inter-
vention had decreased the patients’ symptom load and psychoso-
cial burden and increased their quality of life. After all, we wanted
to know whether a nurse-led intervention had any impact on these
patients’ coping strategies, considered a useful way to reduce
stress and psychiatric symptoms.
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2.1. Study design
We tested the effectiveness of the nurse-led intervention by
setting up an open label, cluster randomised controlled trial in 20
general practitioners’ practices in the city of Hamburg (Germany).
Nurse-led interventions were performed at the primary care
practices. Nurses were assigned to the interventional practices for
12 consecutive months providing services for patients over this
period of time. Nurses followed a practice visitation schedule (once
a week), according to which they worked at a particular practice.
They had their own ofﬁce room inside the practice at their disposal.
At the control practices, the patients received routine GP care. As
an incentive, control practices were offered the nurse-led
intervention for 12 months after closing the RCT.
More information about the study design, the setting and the
intervention is documented in the study protocol (Zimmermann
et al., 2014). The trial is registered at https://www.clinicaltrials.
gov/ct2/show/NCT01726387. Ethics approval was obtained from
the ethics committee of the Hamburg Medical Association,
approval number PV4106.
2.2. Recruitment and randomisation of primary care practices
The city of Hamburg is a large metropolitan area with a
population of 1.8 million. There are about 1000 primary care
practices. Almost 80% of them are operated by a single GP and his/
her practice assistants, whilst about 20% are run by several GPs
sharing the premises and staff. Twenty primary care practices had
to be recruited. Letters with study information were mailed to
postcode-selected primary care practices in ﬁve Hamburg counties
(N = 449) inviting GPs to partake in this trial, about 45% of the
primary care practices in the city of Hamburg.
Inclusion criteria for practices were:
 Willingness to participate in the study regardless of whether the
practice was randomised to the interventional part of the study
or the control arm,
 the availability of a separate room at the practice for the nurses to
conduct the intervention in a protected environment at ﬁxed
appointment times,
 no psychotherapeutic treatment within the practice by the GP
him/herself nor by any other professional at the practice.
The response rate of the invited GPs was quite low (compare
Fig. 1): Only 28 of 449 practices (6.2%) were interested in getting
more information on the project. After we had contacted interested
GPs, we realised that very few practices were able to provide an
additional room for the trial. We started a second round of
invitations via personal telephone calls. We removed 34 practices
from the list (letter undeliverable, rejection in the ﬁrst round),
which left us with a remaining pool of 415 practices. We
telephoned another 184 (44.3%) of the practices, asking them to
reconsider participating in the trial, until we reached our ﬁnal goal
of 20 practices. It took 18 months to complete our practice
recruitment.
2.3. Randomisation of practices
A biometrician (AD), not involved in the ﬁeld work, randomly
allocated participating general practices with a ratio of 1:1 to
either the interventional arm (nurse-led care) or the control arm
(routine care) treating ADSom patients.2.4. Study population and recruitment
We scheduled patient recruitment at the practices on particular
screening days with high patient ﬂows. All patients who had a
personal appointment with their GP were put on a chart and
checked for eligibility criteria.
Eligibility criteria for patients were:
a) age: 18–65 years old,
b) literacy (German),
c) fully able to give consent,
d) sufﬁcient auditory and visual capabilities,
e) currently not in psychotherapeutic treatment,
f) PHQ scoring 5 points or higher.
Eligible patients were informed about the study. Since the
SMADS project included an intervention by a nurse, German
legislation required the GP to explain the study details, screen the
patients and schedule an appointment with the nurse. If the terms
were accepted, patients had to give their written informed consent
to participate in the study. Patients also had to agree to release
their physician from his/her medical conﬁdentiality obligation,
allowing the nurses and the GP to exchange information.
Patients were asked to answer the Patient Health Questionnaire
– German version (PHQ-D), a well-established instrument with
good validity and prognostic capabilities used to screen patients for
anxiety, depressive and somatic symptoms (Gräfe et al., 2004).
Speciﬁcally, we used the:
 7-item general anxiety disorder scale (GAD-7), using four
response categories: “0 = not at all”, “1 = several days”, “2 = more
than half the days”, “3 = nearly every day”.
 9-item depression scale (PHQ-9) whose criteria were also
differentiated by the frequency of their occurrence: “0 = not at
all,”1 = several days”, “2 = more than half the days”, “3 = nearly
every day”.
 15-item somatisation scale (PHQ-15), charting somatic symp-
toms over the past four weeks, using three response categories:
“0 = not at all”, “1 = bothered a little”, “2 = bothered a lot”.
The sum of the points was calculated for each scale. Scores
between 5 and 9 points were considered “mildly impaired”, while
10–14 points described a “moderate” psychological impairment. A
score  15 indicated clinically signiﬁcant psychological distress.
The screening procedure targeted patients scoring 5 points or
higher on any of the three symptom scales. As psychiatric
symptoms may ﬂuctuate daily and overlap signiﬁcantly between
the disorders (Löwe et al., 2008), we expected many patients to
score above the cut-off on any of the scales, emphasising the low-
threshold approach of our nurse-led care model. Patient ﬂow is
displayed in Fig. 1.
2.5. Intervention and control groups
2.5.1. Intervention group: nurse-led care
We implemented the involvement of nurses using case
management and counselling techniques to promote self-man-
agement for ADSom patients. After GPs had commissioned
patients to the trial, the nurses performed an initial assessment,
checking patients’ perspectives, personal resources and their
motivation for change. In cooperation with the patients, they
developed speciﬁc objectives to be achieved over the course of the
trial. Together, they decided on a hierarchy of goals, from smaller to
larger ones, consented and recorded in written form (Pauls and
Reicherts, 2012).
Fig. 1. CONSORT ﬂowchart for the recruitment of primary care practices and patients.
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on how to achieve these goals. The planning of the measures and
concrete self-management support took place in close consulta-
tion with the GPs. After reaching an agreement at the ﬁrst session,
further appointments were scheduled. Over the course of the trial,
nurses could use the following nine modules of intervention to
support their patients (Fig. 2).
Due to many overlapping symptoms in the ﬁeld of anxiety,
depressive and somatoform disorders (Löwe et al., 2008), disorder-overlapping modules were developed. We followed the German
treatment guidelines for anxiety, depression and non-speciﬁc,
functional and somatoform physical complaints (http://www.
awmf.de), particularly those referring to non-medical recommen-
dations:
 Honouring the patients’ treatment preferences, promoting the
patients’ cooperation, building a working relationship,
Fig. 2. Modules of the complex intervention.
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the disease
 Considering previous treatments, severity of illness, co-morbid
disorders, suicide risk
 Considering substance abuse (nicotine, alcohol, medications,
drugs), impairment in daily life, avoidance behaviour, persistent
chronic stressors
 Offering psycho-educational counselling, integration into the
social network, physical and social activation
 Checking availability of treatment options in the patients’ local
vicinity, their economic resources, costs of treatments, patients’
time to access services, particularly if they are not on sick leave
(schedule appointments and travel time).
Thus, the modules were intended to implement case manage-
ment elements in counselling. Just as it was essential to offer low-
threshold, behavioural modules: problem-solving techniques,
relaxation exercises or strengthening self-conﬁdence activities –
all promoting better self-care, i.e. improving self-management.
The counselling process ended with a ﬁnal interview in order to
get patients’ feedback, check goal attainment and preview further
developments. The consultation process was supplemented by the
following measures:
 Case conferences with the GP
 Nurses regularly met with the study GP (EP; GP and psychother-
apist) for joint discussions (supervision)
2.5.2. Control group: routine care
Patients in the routine care arm of the trial were treated by their
GPs according to general clinical practice for ADSom patients,including medications and referral for other treatments as well as
psychotherapy.
Patients in both, the intervention and control groups were re-
assessed 8 weeks and 12 months post baseline at all outcome
measures in order to collect information on the course of
symptoms and the sustainability of the intervention.
2.6. Practice nurses
Our nurse-led trial was designed to employ nurses as health
service providers in primary care. Due to the complexity of the
intervention and our expectations regarding clinical training and
experience, we opted for (external) nurses and against the
assignment of (internal) practice assistants even though working
at an ambulatory practice is rather uncommon for nurses in
Germany (Freund et al., 2015).
The SMADS project eventually hired four ﬁeld nurses, two of
them with a bachelor of science in nursing, one with a master’s in
health sciences, the fourth with a basic nursing education.
Thoroughly instructed by the study GP (EP), the nurses went
through a manualised program, comprising written documenta-
tion and practical training. In order to be prepared for their work at
speciﬁc primary care practices, the nurses had to collect
information about any (psychosocial) services in close vicinity of
their practices. Full-time employed nurses were rotating between
up to four different practices throughout the city of Hamburg.
2.7. Primary outcome measure
2.7.1. General self-efﬁcacy (GSE scale)
We used the GSE scale (Schwarzer and Jerusalem, 1995), a
questionnaire consisting of 10 items ranging from 1 = not at all true,
2 = hardly true, 3 = moderately true and 4 = exactly true, to assess
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utilised tool for assessing self-efﬁcacy and has been translated into
31 languages. It measures a patient’s general sense of perceived
self-efﬁcacy – the belief in one’s own capabilities. It predicts the
patient’s ability to cope with everyday life, as well as his/her ability
to adapt to new situations after experiencing all kinds of stressful
life events (Scholz et al., 2002).
2.8. Secondary outcome measures
2.8.1. Patient health questionnaire (PHQ-D)
For statistical reasons, we decided against the use of the PHQ-D
as the primary outcome even though we used it as a screening tool
to include patients. As every PHQ-D scale is a single measure, not
an overall symptom load, it would have been necessary to do a
power calculation for every single scale, resulting in some
infeasible patient numbers. Besides, this strategy was justiﬁed
by the supreme goal of the study: Supporting self-management,
measured indirectly, using self-efﬁcacy as a proxy. Therefore, we
used the results of the PHQ-D symptom scales as secondary
outcomes.
2.8.2. EQ-5D quality of life
Due to the joint research project “psychenet – Hamburg
Network for Mental Health” (http://www.psychenet.de/en.html –
see funding section) we were asked to assess the patients’ health-
related quality of life using the EQ-5D questionnaire. The EQ-5D, a
5-item questionnaire developed by the EuroQoL Group (http://
www.euroqol.org) with satisfying psychometric properties com-
prised ﬁve dimensions: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression. Due to publications with
reference values for the German general population (Hinz et al.,
2006), we were able to calculate a country-speciﬁc index
indicating a high quality of life if the index was 1 and a very
low quality of life if the index approached 0.
2.8.3. Freiburg questionnaire of coping with illness (FQCI)
Coping strategies were assessed using the “Freiburg Question-
naire of Coping with Illness” (Muthny, 1989), an instrument based
on the transactional coping concept of Lazarus and Folkman. It
assessed a broad range of cognitive, behavioural and emotional
aspects of coping with an illness. Investigators used the short, self-
rating version, consisting of 35 items. It covered a broad range of
cognitive, behavioural and emotional aspects of coping with an
illness, clustered in ﬁve subscales: “depressive coping”, “active,
problem-oriented coping”, “distraction”, “quest for meaning/
religion” and “trivialising”. Patients were asked how many of
the items applied to his or her situation last week: “not at all”,
“little”, “moderately”, “much”, “very much”. Higher values
indicated a stronger presence of the respective coping strategy.
2.9. Power calculation and sample size
We calculated a sample size of 220 patients based on an
expected difference between the intervention and the control
group of 2.7 points and a common standard deviation of 5.4 points
on the General Self-Efﬁcacy scale as the primary outcome 12
months post baseline. In order to achieve a sufﬁcient study power
of 80%, we had to take an intra-cluster correlation of 0.05 into
consideration. Therefore we needed a minimum of 20 randomised
clusters with an average cluster size of 11 patients. Anticipating a
dropout rate of 33% on the patient level, we had to recruit 340
patients (on average 17 patients per cluster). The numbers and the
patient ﬂow are shown in Fig. 1.2.10. Statistical analysis
A descriptive analysis of baseline characteristics was per-
formed. For the primary outcome GSE, a linear mixed model with
an adjustment for clusters, was calculated for the difference
between the intervention and control groups after 12 months.
Intraclass coefﬁcients (ICC) will be reported. The variable “group”
(IG vs. CG) was considered a ﬁxed effect, while the practice was
considered a random effect under the control of the baseline
covariates (baseline values of GSE and other confounders such as
the PHQ-D and patient’s age, gender, education, and utilisation of
the healthcare system, as well as GP’s age, gender and status
of practice (single or group). The two-sided a-level was set to
0.05.
The analyses of the primary outcome were based on an
intention-to-treat (ITT) analysis: All patients enrolled in the study,
who had fully completed the baseline assessment, were assessed
again at week 8 post baseline and 12 months post baseline. If
patients did not answer the invitation for assessment or could not
be reached at all (i.e. if they dropped out before these assessments),
their last available values were used, their last observation was
carried forward (LOCF method) for the ITT-analysis. We reported
the results as adjusted mean differences with their 95% conﬁdence
intervals and effect sizes using Cohen’s d as parameter. ICC will also
be reported.
In further analyses, we calculated several analogous linear
mixed models with repeated measurements of the GSE as primary
outcome, and of the PHQ-D, EQ-5D and FQCI as secondary
outcomes. We calculated the interaction between “group” (IG vs.
CG) and “time” (8 weeks post baseline, 12 months post baseline).
In a sensitivity analysis, we calculated results of the observed
cases (OC) for the primary outcome. This analysis will include only
those patients who did not drop out and completed their ﬁnal
assessment. In a second sensitivity analysis, we replaced missing
values using a multiple imputation approach (N = 100 imputa-
tions). Analyses were done using Stata 14.
3. Results
3.1. Patient ﬂow and retention
325 patients fully completed the baseline assessment. 134
patients were enrolled in the intervention group (IG), 191 in the
control group (CG) (Fig. 1). As of follow-up (median 69 days post
baseline), 94 IG patients (70.1%) and 133 CG patients (69.3%)
completed the assessment. Follow-up 2 (median 406 days post
baseline) was completed by 61 IG patients (45.5% of baseline
population) and 107 CG patients (56.0%). Dropouts did not differ in
gender, education, employment or any of the primary or secondary
outcomes at baseline. Only age was highly signiﬁcant regarding
withdrawing from or completing the trial (N = 157 dropouts, mean
age 36.2, 95% CI 34.2–38.2; N = 168 completers, mean age 44.0, 95%
CI 42.1–45.8; p < 0.001).
3.2. Utilisation of nurse-led care
Four nurses (2.5 full-time equivalents) provided self-manage-
ment support for 125 of the 134 (93.3%) patients in the
intervention group, who met a nurse for at least one scheduled
appointment. On average, nurses provided care for 31.2 (range 16–
41) patients, generally, each nurse offered 133.8 sessions (standard
deviation 31.8; range 71–171). Overall, patients had four sessions
(standard deviation 2.8; range 1–17), with a mean of 53.8 min at
their disposal. 84.0% of the patients had two or more sessions,
21.6% had ﬁve or more sessions.
Table 1
Sample characteristics at baseline.
Variable Intervention group (IG) Control group (CG)
Number of patients 134 191
Age in years (mean  SD) 39.5  13.2 40.7  13.1
Gender (female) in % (95% CI) 66.4 (58.3–74.5) 67.0 (60.3–73.7)
Level of education – CASMIN classiﬁcation in % (95% CI)
Low 26.1 (18.6–33.6) 22.5 (16.5–28.5)
Middle 56.7 (48.2–65.2) 59.2 (52.1–66.2)
High 17.2 (10.7–23.6) 18.3 (12.8–23.8)
Employment situation in % (95% CI)
Without occupation (incl. unemployed) 27.6 (19.9–35.3) 31.9 (25.3–28.6)
Minor occupation 5.2 (1.4–9.0) 7.3 (3.6–11.0)
Part-time occupation 18.7 (11.9–25.9) 15.2 (10.0–20.3)
Full-time occupation 47.0 (38.4–53.6) 44.0 (36.9–51.1)
No response 1.5 (0–3.6) 1.6 (0–3.3)
SD: Standard Deviation; CI: Conﬁdence Interval; CASMIN Comparative Analysis of Social Mobility in Industrial Nations.
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Baseline characteristics are displayed in Table 1. Age, gender,
formal school education according to the “Comparative Analysis of
Social Mobility in Industrial Nations“- (CASMIN) classiﬁcation
(Brauns and Steinmann, 1999) and occupational status were
equally distributed between IG and CG at baseline.
3.4. Primary outcome
The between-group difference (IG vs. CG) for the primary
outcome (self-efﬁcacy) increased from the baseline by 1.65 points
(95% CI 0.52 to 2.78) in favour of the intervention group (p = 0.004)
when applying the last observation carried forward imputation
strategy. This amounted to a small Cohen’s d effect size of 0.33. We
found a signiﬁcant interaction of time and group in the repeated
measurement model, indicating a growing effect over time
(Cohen’s d = 0.44) in favour of the intervention (see Table 2). This
effect is plotted in Fig. 3.
3.5. Secondary outcomes
We found no interaction between time and group in the
repeated measurement model for any of the secondary outcome
measurements (see Table 2). At follow-up 2, the mean change inFig. 3. Mean changes from baseline to follow-up 2 for the primary outcomsomatic symptoms between the groups did not differ signiﬁcantly
(BL – T2 mean change 0.98 (0.11 to 2.07); p = 0.078; Cohen’s
d = 0.20). Depressive symptoms differed signiﬁcantly between the
groups (BL – T2 mean change 1.05; 95% CI 0.01 to 2.08); p = 0.046;
Cohen’s d = 0.23). The anxiety scale showed an adjusted mean
difference between groups of 1.28 points in symptom reduction
(95% CI 0.36 to 2.21), signiﬁcantly in favour of the IG (p = 0.006;
Cohen’s d = 0.32).
The adjusted mean group difference for the EQ-5D quality of life
score did not show a signiﬁcant change between the groups at
follow-up 2. All pre-post group comparisons for the FQCI showed
marginal but signiﬁcant changes from baseline in “depressive
coping” and “problem-oriented coping”. The effect size for
“depressive coping” was 0.24 (p = 0.04), for “active, problem-
oriented coping” 0.28 (p = 0.012). We could not ﬁnd a substantial
impact of the intervention in the other scales of the FQCI (compare
Table 2).
3.6. Sensitivity analysis
Compliant with the study protocol, we investigated the robust-
ness of the intention-to-treat results and the plausibility of our
imputation strategy. Firstly, we calculated the results of all patients
who completed the trial (observed cases). Secondly, we analysed the
SMADS trial data using multiple imputation techniques.e self-efﬁcacy (ITT-LOCF population, repeated measurement model).
Table 2
Effects of nurse-led intervention vs. routine care on primary and secondary outcomes.
Primary outcome Intervention group Control group Between-group difference
Unadjusted
mean (SD); [N]
Change from baseline (ITT-LOCF) Unadjusted mean
(SD); [N]
Change from baseline (ITT-LOCF) (IG vs. CG) (ITT-LOCF) Interaction
group time
p value
Effect size
Cohen’s d
ICC
in %
Adjusted mean difference
(95% CI); [N]; p-value
Adjusted mean difference
(95% CI); [N]; p-value
Adjusted mean difference
(95% CI); [N]; p-value
(BL – T1) (BL – T1) (BL – T1)
(BL – T2) (BL – T2) (BL – T2)
Self-efﬁcacy BL – T2
GSE BL 25.3 (5.6); [134] 1.54 (0.70–2.38); [134]; *** 28.6 (5.8); [191] 0.11 (0.82 to 0.60); [191]; # 1.65 (0.52 to 2.78); [325]; ** n/a 0.33 11.3
GSE T2 29.1 (6.1); [56] 28.1 (6.6); [105]
Self-efﬁcacy – repeated measurement model (BL – T1; BL – T2)
GSE BL 25.3 (5.6); [134] 28.6 (5.8); [191]
GSE T1 26.8 (6.1); [91] 0.83 (0.15–1.51); [134]; ** 28.2 (6.1); [129] 0.25 (0.31 to 0.82); [191]; # 0.58 (1.48 to 0.33); [325]; # *** 0.14 7.9
GSE T2 29.1 (6.1); [56] 1.63 (0.95–2.31); [134]; *** 28.1 (6.6); [105] 0.15 (0.71 to 0.41); [191]; # 1.78 (0.87 to 2.68); [325]; *** 0.44
Secondary outcomes – repeated measurement model (BL – T1; BL – T2)
PHQ
PHQ somatoform symptoms BL 12.1 (4.9); [134] 10.7 (5.0); [191]
PHQ somatoform symptoms T1 9.1 (5.2); [94] 1.98 (2.78 to 1.17); [134]; *** 9.4 (5.9); [132] 1.28 (1.97 to 0.58); [191]; *** 0.70 (0.39 to 1.79); [325]; # # 0.15 13.8
PHQ somatoform symptoms T2 7.8 (4.7); [59] 2.67 (3.48 to 1.86); [134]; *** 8.6 (5.2); [105] 1.69 (2.38 to 1.00); [191]; *** 0.98 (0.11 to 2.07); [325]; # 0.20
PHQ depressive symptoms BL 11.7 (5.5); [134] 8.7 (5.4); [191]
PHQ depressive symptoms T1 8.2 (5.4); [94] 1.81 (2.58 to 1.04); [134]; *** 7.9 (5.9); [132] 1.07 (1.72 to 0.42); [191]; *** 0.74 (0.29 to 1.78); [325]; # # 0.16 11.5
PHQ depressive symptoms T2 7.2 (5.2); [59] 2.42 (3.19 to 1.66); [134]; *** 7.5 (5.6); [105] 1.38 (2.03 to 0.72); [191]; *** 1.05 (0.01–2.08); [325]; * 0.23
PHQ anxiety symptoms BL 9.6 (5.4); [134] 7.0 (5.3); [191]
PHQ anxiety symptoms T1 6.7 (5.2); [94] 1.55 (2.24 to 0.86); [134]; *** 6.5 (5.3); [132] 0.69 (1.26 to 0.12); [191]; * 0.86 (0.06 to 1.79); [325]; # # 0.21 3.6
PHQ anxiety symptoms T2 5.7 (4.9); [59] 1.96 (2.65 to 1.26); [134]; *** 6.5 (5.0); [105] 0.67 (1.24 to 0.10); [191]; * 1.28 (0.36–2.21); [325]; ** 0.32
EQ-5D – QoL
EQ5D Index BL 0.8 (0.21); [133] 0.78 (0.25); [189]
EQ5D Index T1 0.83 (0.21); [94] 0.03 (0.01–0.06); [133]; * 0.82 (0.24); [131] 0.03 (0.01–0.05); [189]; * 0 (0.04 to 0.3); [322]; # # 0.02 6.6
EQ5D Index T2 0.85 (0.21); [53] 0.03 (0–0.06); [133]; * 0.79 (0.25); [94] 0.01 (0.01 to 0.04); [189]; # 0.02 (0.05 to 0.02); [322]; # 0.10
FQCI
Depressive coping BL 2.9 (0.84); [127] 2.6 (0.81); [185]
Depressive coping T1 2.5 (0.91); [89] 0.24 (0.34 to 0.14); [127]; *** 2.4 (0.88); [126] 0.17 (0.25 to 0.08); [185]; *** 0.07 (0.07 to 0.21); [312]; # # 0.12 5.4
Depressive coping T2 2.3 (0.85); [53] 0.29(0.39 to 0.18); [127]; *** 2.4 (0.9); [90] 0.15 (0.23 to 0.06); [185]; *** 0.14 (0.28); [312]; * 0.24
Active, problem-oriented coping BL 3.1 (0.8); [127] 3.1 (0.8); [187]
Active, problem-oriented coping T1 3.2 (0.78); [90] 0.03 (0.08 to 0.15); [127]; # 3.1 (0.83); [125] 0.10 (0.19 to 0.01); [187]; * 0.13 {0.29 to 0.02); [314]; # # 0.20 9.3
Active, problem-oriented coping T2 3.2 (0.75); [53] 0.09 (0.02 to 0.21); [127]; # 3.1 (0.74); [89] 0.10 (0.19 to 0.01); [187]; * 0.19 (0.35 to 0.04); [314]; * 0.28
Distraction BL 3.0 (0.71); [130] 3.0 (0.7); [189]
Distraction T1 3.0 (0.64); [92] 0.02 (0.07 to 0.12); [130]; # 2.9 (0.78); [130] 0.05 (0.13 to 0.03); [189]; # 0.08 (0.21 to 0.06); [319]; # # 0.13 <1
Distraction T2 3.0 (0.79); [53] 0 (0.10 to 0.09); [130]; # 3.1 (0.68); [91] 0.01 (0.06 to 0.09); [189]; # 0.02 (0.11 to 0.15); [319]; # 0.03
Quest for meaning/religion BL 2.5 (0.71); [128] 2.5 (0.75); [184]
Quest for meaning/religion T1 2.4 (0.68); [89] 0.08 (0.16 to 0); [128]; 0.053 2.2 (0.78); [127] 0.07 (0.13 to 0); [184]; * 0.01 (0.09 to 0.12); [312]; # # 0.03 4.0
Quest for meaning/religion T2 2.3 (0.68); [52] 0.08 (0.17 to 0); [128]; 0.048 2.4 (0.71); [90] 0.04 (0.11 to 0.03); [184]; # 0.04 (0.07 to 0.16); [312]; # 0.09
Trivialising BL 2.8 (1.0); [125] 2.4 (0.84; [183]
Trivialising T1 2.4 (1.0); [90] 0.23 (0.41 to 0.06); [125]; ** 2.2 (0.99); [129] 0.17 (0.32 to 0.02); [183]; * 0.06 (0.17 to 0.39); [308]; # # 0.06 17.5
Trivialising T2 2.3 (0.93); [55] 0.34 (0.51 to 0.16); [125]; *** 2.3 (0.99); [95] 0.13 (0.28 to 0.02); [183]; # 0.21 (0.03 to 0.44); [308]; # 0.20
SD: StandardDeviation; N: Numbers; ITT-LOCF: Intention-To-Treat Analysis Last Observation Carried Forward; CI: Conﬁdence Interval; BL: Baseline; T1:median 69days post baseline; T2:median 406days post baseline; GSE: General
Self-Efﬁcacy Scale; PHQ: Patient Health Questionnaire; EQ-5D QoL: Euroqol-5D Quality of Life Scale; FQCI: Freiburg Questionnaire for Coping with Illness; ICC: Intraclass Coefﬁcient, variance explained by cluster; data adjusted for
patient’s gender, age, education, utilisation of health care system, baseline measures, age of general practitioner, type of practice (single or group), gender of general practitioner; symbols for p-values: * p<0.05; ** p<0.01 ***
p<0.001 # p>0.05; n/a not applicable
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Table 3
Comparison of ITT-LOCF, OC and MI strategy to handle missing data in primary outcome self-efﬁcacy calculations.
Primary
outcome
Intervention group Control group Between-group difference
Unadjusted mean
(SD); [N]
Change from baseline Unadjusted mean
(SD); [N]
Change from baseline (intervention vs. control) Effect size
Cohen’s d
Adjusted mean difference
(95% CI);
[N]; p-value
Adjusted mean difference
(95% CI);
[N]; p-value
Adjusted mean difference
(95% CI);
[N]; p-value
Self-efﬁcacy T0 – T2 (ITT-LOCF)
GSE BL 25.3 (5.6); [134] 1.54 (0.7–2.38); [134]; *** 28.6 (5.8); [191] 0.11 (0.82 to 0.6); [191]; # 1.65 (0.52–2.78); [325]; ** 0.33
GSE T2 29.1 (6.1); [56] 28.1 (6.6); [105]
Self-efﬁcacy T0 T2 (Observed cases analysis)
GSE BL 25.3 (5.6); [134] 28.6 (5.8); [191]
GSE T2 29.1 (6.1); [56] 2.68 (1.09–4.27), [56]; *** 28.1 (6.6); [105] 0.45 (1.65 to 0.75); [105]; # 3.13 (1.07–5.18); [161]; ** 0.51
Self-efﬁcacy T0 T2 (Multiple imputation, N = 100 imputations)
GSE BL 25.3 (5.6); [134] 28.6 (5.8); [191]
GSE T2 29.1 (6.1); [56] 1.39 (0.10 to 2.88); [134]; # 28.1 (6.6); [105] 0.06 (1.14 to 1.26); [191]; # 1.33 (0.45 to 3.12); [325]; # 0.15
SD: Standard Deviation; N: Numbers; ITT-LOCF: Intention-To-Treat Analysis Last Observation Carried Forward; CI: Conﬁdence Interval; OC Observed Cases; MI Multiple
Imputation; BL: Baseline; T2: median 406 days post baseline; GSE: General Self-Efﬁcacy Scale; data adjusted for patient’s sex, age, education, utilisation of health care system,
GSE at baseline, age of general practitioner, type of practice (single or group), sex of general practitioner; symbols for p-values: * p < 0.05; ** p < 0.01 *** p < 0.001 # p > 0.05
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cases analysis conﬁrmed the results of the ITT-LOCF analysis (see
Table 3). IG members who fully completed the assessments,
reported that they had increased their self-efﬁcacy by 3.13 (95% CI
1.07 to 5.18; p = 0.004; Cohen’s d = 0.51) compared to the CG
members who also had fully completed the assessments.
Multiple imputations (N = 100 imputations) showed a similar
magnitude of increase in self-efﬁcacy in favour of the IG as in the
ITT-LOCF approach – although it remained insigniﬁcant (mean
change 1.33 points; 95% CI 0.45 to 3.12; p = 0.147).
4. Discussion
This paper reports the results of the SMADS trial, the ﬁrst nurse-
led interventional study for patients with anxiety, depressive or
somatic symptoms, implemented as a collaborative care model in
primary care in Germany. Findings of this randomised controlled
study indicate an increase in self-efﬁcacy (used as a proxy for self-
management) over a period of 12 months compared to patients in
the control group. These results ﬁt quite well into the growing body
of research conﬁrming the important role of nurses in primary care
(Christensen et al. 2008; Thota et al., 2012; Archer et al., 2012).
Thus, nurses do improve patients’ self-management skills as they
utilise low threshold strategies, are at eye level with their patients,
pass on information and enhance patients’ self-care.
An extended program to support self-management in patients
with psychological symptoms in primary care enhanced their self-
efﬁcacy – a result explained primarily through the broad range of
options our nurses were able to choose from in the modularised,
complex intervention (Zimmermann et al., 2015a).
In order to facilitate the intervention, it is useful to evaluate a
patient’s motivation to change prior to the onset of the
intervention (Zimmermann et al., 2015b). It may help to judge a
patient’s commitment to an intervention as well as to the goals to
be attained in the time to come. Low motivation to change is
associated with a very disproportionate conviction of a patient’s
self-efﬁcacy, which can certainly uphold and eventually exacerbate
anxious, depressive or somatic symptoms.
Nevertheless, a reduction in the PHQ symptom scores was
observed in IG as well as in CG. The IG showed a higher symptom
reduction as patients had higher baseline scores. The mean
symptom reduction between groups showed small effects fordepressive and anxiety symptoms. This ﬁnding was much weaker
than the results of other nurse-led, collaborative care interventions
(Aragones et al., 2012; Oosterbaan et al., 2013; Richards et al.,
2013), studies that were tailored to reduce depressive symptoms.
But symptom reduction was just a secondary outcome of this
intervention. One other reason for the lack of symptom reduction
might have been the very low inclusion criterion of a minimum of 5
points on any of the PHQ-D (anxiety or depressive or somatic
symptoms) scales, leading to a lower average impairment as in any
of the above mentioned studies.
4.1. Limitations of the study
We successfully implemented a collaborative care model in ten
ambulatory healthcare practices in Germany. However, we had to
tackle a broad range of problems. We faced enormous difﬁculties
recruiting practices as it was completely foreign to German
healthcare providers and German GPs to have a nurse do
collaborative care. Practices needed to be personally convinced
to take part, sometimes requiring up to ﬁve phone calls just to
contact the GPs, who privately own and run their practices and are
responsible for their commercial success. Nevertheless, there was a
need for more healthcare research in the primary care setting in
Germany. Yet, we had one question to consider: Would it be
possible to integrate German primary care practices into a research
infrastructure (Hummers-Pradier et al., 2012)? The problems and
barriers we had to face as we set up the trial were similar to those
of the only other trial that had employed nurses in the German
ambulatory practice setting (Herber et al., 2009).
After we had recruited the necessary number of practices, more
problems had to be solved. In Germany, recruiting patients for an
interventional study where a nurse provided patient services could
only be done after a GP had delegated medicinal work to the nurse.
Thus, patients were screened using the PHQ-D, but it were the GPs
who decided whom of the patients they were going to ask to take
part in the interventional study. This selection bias could not be
appropriately addressed in an open label trial.
As shown in the results section (Table 2), the selection bias led
to differing baseline values of primary and secondary outcomes
between the intervention and the control group. In order to
evaluate the impact of these differences, we applied Bland-
Altman-Plots (Bland and Altman, 1995; Bland and Altman, 2010) to
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over time. We used these plots to check if we could compare the
different baseline values of IG and CG. The plots (not shown, but
available from the authors) put the arithmetic mean of the two
groups on the x-axis and the mean group difference on the y axis,
casting their respective regression lines. As these lines did not
cross each other, the baseline and follow-up values of both groups
were comparable even though the baseline values differed
signiﬁcantly. We plotted graphs for all outcomes and found no
crossing regression lines.
Additionally, the attrition bias was an important limitation of
the SMADS study. Firstly, we did not reach the number of patients
we needed to recruit according to the power calculation. Secondly,
we intended to achieve an 80% power for the trial, but we failed to
reach the target as we lost too many patients to follow-up. Thirdly,
our ICCs showed a high variation, most of them being greater than
the expected 0.05. Fourthly, the issue of handling missing endpoint
values complicated the data interpretation: There is little evidence
on how much missing data can be adequately handled by any
method, ITT-LOCF or multiple imputations. In a simulation study,
Unnebrink and Windeler (2001) found imputation methods
suitable for dropout rates of less than twenty per cent and similar
courses of disorders. The authors could not give recommendations
for larger dropout rates. In our study, 45.5% of patients in the
intervention and 56.0% of patients in the control group had
dropped out before follow-up 2. We reported our ITT-results using
the last available values of the patients (LOCF method). We tested
the robustness of our results, using an observed cases analysis and
a multiple imputation analysis. Results of the observed cases
supported the trend of our results, an increased self-efﬁcacy in the
IG, multiple imputation did not.
Finally, we deliberately did not evaluate any economic outcome.
Implementation and organisational costs greatly outweighed any
possible economic beneﬁt. Only a much larger study over a much
longer period of observation, documenting any utilisation of the
healthcare system in cooperation with statutory health insurance
companies, might meet these targets.
4.2. Strengths of the study
Nonetheless, against all odds, we set up the SMADS trial in a
very sceptical healthcare environment. We recruited a reasonable
number of patients to broaden the scope of patients in need:
patients usually not properly provided with optimal care. Although
dropout rates were high, and the resulting study power was
insufﬁcient, LOCF-ITT data showed a signiﬁcant increase in self-
efﬁcacy. The IG showed a signiﬁcantly lower self-efﬁcacy at
baseline compared to the CG. But the IG patients’ self-efﬁcacy
noticeably increased at 12 months post baseline, now scoring
signiﬁcantly better than the CG at that time.
We were the ﬁrst to introduce a nurse to work collaboratively
with a GP in Germany’s healthcare system, to improve healthcare
for patients with anxiety, depressive or somatic symptoms. We
implemented a complex interventional study and showed the
study to be feasible. The SMADS trial recruited patients with low
and high psychological impairment, using a low cut-off for
inclusion. In doing so, we wanted to cover several aspects of
prevention, hoping that our efforts to offer patients early support
would prevent aggravating, chronic psychosomatic impairment
later on in their lives.
5. Conclusion
A low threshold, nurse-led intervention, implemented as a
collaborative care model in ten primary care practices in Germany,
increased self-efﬁcacy in patients with anxiety, depression orsomatic symptoms compared to patients of ten control practices.
For the ﬁrst time in the German healthcare system, the SMADS trial
validated the belief that a nurse could successfully complement the
work of a general practitioner by introducing new case manage-
ment elements into primary care. This was especially true when it
came to self-management support for patients with psychoso-
matic symptoms, targeting their psychosocial needs. Nevertheless,
results need to be conﬁrmed through further research by more
powerful trials, while taking the speciﬁc situation of primary care
in Germany into account.
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